A class action lawsuit is a legal suit initiated by individuals who were injured as the result of using or being selling an anti-aging product called Plavix. The plaintiff in this class action lawsuit, Plavix LLC, claimed that the manufacturer of Plavix, Actives, knew or ought to have known that the product it was selling, Plavix Max, is an unlicensed anabolic and steroid.
This is based on the fact that the manufacturer of this anti-aging drug offered a money back guarantee to individuals who purchased a bottle of Plavix and within a few weeks of purchasing said bottle of Plavix they experienced extreme side effects which resulted in them requiring another large amount of the anti-aging drug. According to court documents, a few months after these individuals filed their lawsuit; the defendant refused to cease selling Plavix and instead, released another batch of the drug.
Plavix Class Action Lawsuit
This second batch of the anti-plaque drugs contained higher concentrations of the active ingredient called clopidogrel. According to plaintiffs in the lawsuit, these plaques increased in size, their shape changed, and their contour became significantly different from the first batch of plaques. Additionally, the majority of the plaques developed nerve damage and permanent visual impairment.
Furthermore, several plaintiffs also suffered from digestive problems including frequent gas and bloating, constipation, diarrhea, and vomiting; as well as damage to the cardiovascular system including low blood pressure, heart attack, stroke, and heart failure.
Upon learning of these results, the plaintiffs then filed a lawsuit against Actives International, claiming that they had a duty to warn consumers that Plavix can cause a heart attack or a stroke.
The defendants denied these claims, stating that all that the plaintiffs would have gained through a class action lawsuit would have been a lower price for their products. In addition, defendants stated that there was no evidence linking any of the Class Action lawsuit plaintiffs with a current or prior heart attack or stroke.
Plaintiffs responded by asking the judge to award punitive damages on the companies’ behalf, arguing that the defendants did not take reasonable steps to warn the public of the risk of taking Plavix. The court has held that plaintiffs have standing to sue, but they are asking for $100 million in compensatory and therapeutic damages.
The class action lawsuit involves a number of different cases, each with its own set of symptoms that will trigger a claim for compensatory and therapeutic damages.
Among the different types of symptoms, the two most common include gastrointestinal bleeding and a potential heart attack. If gastrointestinal bleeding is present, this can be due to the blood clotting tendency of clopidogrel, which is known to cause gastrointestinal bleeding. Additionally, if a future heart attack is caused by taking clopidogrel, that could be classified as a Class Action Lawsuit against the manufacturer of Plavix.
The manufacturer’s defense was that their drug was designed for the prevention of gastrointestinal bleeding, and not heart attacks plus aspirin.
Additionally, they claimed that their product did not contain ingredients which could cause any type of heart attacks or cardiovascular problems. The defense further argued that the Class Action Lawsuit should be dismissed because the complaint was technically fraudulent, as the ingredients in the clopidogrel plus aspirin are safe when used as directed. The FDA itself has determined that this was the case, stating that Plavix’s claims are truthful, but misleading in that it implies that Plavix will cause a heart attack, when in reality, there is no link between the two.
As expected, the class action lawsuit was eventually dropped, but not before the plaintiff received a great deal of settlement money.
As a result of this, the FDA and the Food and Drug Administration have received a lot of bad publicity. Many people are calling for tighter regulations on these drugs, and they may become even more dangerous than they are today. While they cannot be completely banned, the Food and Drug Administration is considering such a drastic measure. In the meantime, Plavix has continued to be aggressively marketed, even suing and defending itself against the Class Action Lawsuit.